AP2338A - A vaccine - Google Patents
A vaccineInfo
- Publication number
- AP2338A AP2338A APAP/P/2004/003131A AP2004003131A AP2338A AP 2338 A AP2338 A AP 2338A AP 2004003131 A AP2004003131 A AP 2004003131A AP 2338 A AP2338 A AP 2338A
- Authority
- AP
- ARIPO
- Prior art keywords
- lipid
- infectious organism
- aqueous phase
- phase
- leukocyte fraction
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
A therapeutic vaccine is prepared by a method which includes the steps of extracting, with a lipid-extracting solvent, a biological fluid obtained from a person or animal infected with a lipid-containing infectious organism, the biological fluid containing the lipid-containing infectious organism, and the extraction producing an aqueous phase which contains the infectious organism with the lipid substantially removed and a lipid-containing phase, and separating the aqueous phase from the lipid-containing phase. A leukocyte fraction is isolated from the blood of the person or animal, the isolation being conducted so that the leukocyte fraction is substantially free of plasma, free lipid-containing infectious organism and free antibodies to the lipid-containing infectious organism, and at least some of the aqueous phase is combined with at least some of the leukocyte fraction to produce the vaccine.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ZA200307110 | 2003-09-11 |
Publications (2)
Publication Number | Publication Date |
---|---|
AP2004003131A0 AP2004003131A0 (en) | 2004-09-30 |
AP2338A true AP2338A (en) | 2011-12-16 |
Family
ID=39787950
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
APAP/P/2004/003131A AP2338A (en) | 2003-09-11 | 2004-09-09 | A vaccine |
Country Status (3)
Country | Link |
---|---|
AP (1) | AP2338A (en) |
OA (1) | OA12855A (en) |
ZA (1) | ZA200407246B (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992022572A1 (en) * | 1991-06-13 | 1992-12-23 | Replico Medical Ab | New hiv-1 gag and env peptides, diagnostic |
-
2004
- 2004-09-09 ZA ZA2004/07246A patent/ZA200407246B/en unknown
- 2004-09-09 AP APAP/P/2004/003131A patent/AP2338A/en active
- 2004-09-10 OA OA1200400240A patent/OA12855A/en unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992022572A1 (en) * | 1991-06-13 | 1992-12-23 | Replico Medical Ab | New hiv-1 gag and env peptides, diagnostic |
Also Published As
Publication number | Publication date |
---|---|
OA12855A (en) | 2006-09-15 |
AP2004003131A0 (en) | 2004-09-30 |
ZA200407246B (en) | 2005-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2013088148A3 (en) | Method of treatment employing therapeutic t cell product from mobilised donors | |
MY155236A (en) | Influenza virus-like particles (vlps) comprising hemagglutinin produced within a plant | |
AUPQ846900A0 (en) | A vaccine | |
WO2006015115A3 (en) | Potent immunostimulatory extracts from microalgae | |
MX2012005598A (en) | Hydrophilic filtration during manufacture of vaccine adjuvants. | |
DE602004022305D1 (en) | PROCESS FOR THE SEPARATION AND RECOVERY OF 3-HYDROXYPROPIONIC ACID AND ACRYLIC ACID | |
Zhang et al. | Adjuvant-active aqueous extracts from Artemisia rupestris L. improve immune responses through TLR4 signaling pathway | |
BR112012016048A2 (en) | "plasmodium sp. infected reticulocyte derived exosomes, method of obtaining them and uses thereof". | |
WO2005058950A3 (en) | Methods for generating immunity to antigen | |
WO2005101966A3 (en) | Lipid-extracted therapeutic vaccine and method of use | |
WO2006045532A3 (en) | Virosome particles comprising antigens from influenza virus and hepatitis b virus | |
WO2003090687A8 (en) | Using heat shock proteins to increase immune response | |
MX344544B (en) | Blood stage malaria vaccine. | |
AP2338A (en) | A vaccine | |
TW200500331A (en) | Process for the separation, by countercurrentwise liquid-liquid extraction, of a glyoxal diacetal from a crude mixture comprising it | |
CA2467265A1 (en) | Pharmaceutical composition for enhancing immunity, and extract of poria | |
CY1106619T1 (en) | METHOD OF PREPARING AN ISOLATED EXTRACT OF THE EUROPEAN-L CYCLAMINE PLANT AND ITS USE AS A THERAPEUTIC AGENT | |
DE60319840D1 (en) | Poria extract free of Secolanostanderivaten containing Lanostanderivate for immune enhancement | |
PH12020550193A1 (en) | Photochemical preparation method for autologous plasma inactivated vaccine for treating aids | |
CA2519012C (en) | A method for the in vitro assessment of the progression status of an infection by an hiv virus in an individual | |
ATE471155T1 (en) | NEW VACCINE ADJUVANT AND ITS PRODUCTION AND USE | |
WO2004018699A3 (en) | Extraction and concentration method | |
WO2009114202A3 (en) | Vaccine and immunization method using plasmodium antigen 2 | |
CN104447780B (en) | A kind of method extracting sesamin from sesame | |
WO2001030989A3 (en) | Method for creating divergent populations of nucleic acid molecules and proteins |